Is it possible to find cures for 100 rare diseases in a decade or less? Yes, says Blake Borgenson, CTO of Recursion Pharmaceuticals. The company is making a big bet on the power of machine learning to speed discovery, and the bet seems to be paying off. Borgenson took us inside the company’s ongoing work to use machine learning and data visualizations to develop new drugs fast. He also explained how open source software helps his team achieve those goals.
Sourced through Scoop.it from: enterprisersproject.com
